News

Drug middlemen once again were on the hot seat at a congressional hearing on Wednesday. The hearing by the House Education and Workforce...

The 118th Congress is off to a great start in shining a light on the harmful practices of pharmacy benefit managers (PBMs) and the...

House Energy and Commerce Committee cleared a PBM bill that seems to contain more transparency loopholes and makes more limited policy...

Today, U.S. Senator Roger Marshall (R-KS) joined Senators Bob Menendez (D-NJ) and Marsha Blackburn (R-TN), Senate Finance Chairman Ron...

Agency issues order to additional GPO as it examines the impact of vertically integrated PBMs on prescription drug prices and access As...

After starting with generic drugs, Mark Cuban is coming for a blockbuster. Starting in July, a biosimilar version of the world’s...

The group representing state insurance commissioners is seeking information from the Justice Department and Federal Trade Commission...

In The Top Pharmacy Benefit Managers of 2022: Market Share and Trends for the Biggest Companies, I shared Drug Channels Institute's...

US authorities are looking into new groups that were formed to negotiate drug discounts but may actually be further obscuring how much...

In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players. Below,...

One way or another, it looks like the drug supply chain middlemen known as pharmacy benefit managers, or PBMs, are going to be pulled out...

A key Senate committee last week advanced a bill that includes a number of significant reforms to pharmacy benefit managers, including a...

The prescriptions with the most eye-popping price tags — like cancer meds that can cost more than $20,000 a month — are usually...

For two decades, patients and physicians eagerly awaited a lower-cost version of the world’s bestselling drug, Humira, while its maker,...

Despite pushback from Republicans, a key Senate committee has advanced a bill that aims to reform pharmacy benefit managers, including a...

The Protecting Patients Against PBM Abuses Act will bring meaningful reforms to help lower out-of-pocket costs for prescription drugs...

Leading Patient, Provider, Pharmacy, Labor, Anti-Monopoly and Employer Groups Seek Congressional Reforms to Require PBM Transparency,...

The Minnesota Department of Commerce today announced it has levied a $500,000 penalty against Caremark after alleging that Caremark...

The House Energy and Commerce Committee Subcommittee on Health this week held a legislative hearing entitled, “Lowering Unaffordable...

The Senate Finance Committee announced a set of proposed policy solutions to address challenges in the prescription drug supply chain,...

From the early days of the caucuses through the general election, Iowans make a point to ask tough questions that highlight the...

New Poll Finds 87% of Respondents Support Regulating Pharmacy Benefit Managers Salem, Ore. – With the Beaver State already facing...

Several Congressional Committees recently have held hearings where criticism of harmful PBM business practices has taken center stage....

Today, U.S. Representatives Dusty Johnson (R-S.D.) and Abigail Spanberger (D-VA-07) introduced a bipartisan bill that would prohibit...